HighTower Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-500
Closed -$1.39K 3871
2025
Q2
$1.39K Buy
+500
New +$136K ﹤0.01% 3720
2023
Q2
Sell
-100
Closed -$2.94K 3475
2023
Q1
$2.94K Buy
+100
New +$18.1K ﹤0.01% 3268
2022
Q3
Sell
-100
Closed -$2K 3186
2022
Q2
$2K Buy
+100
New +$21.2K ﹤0.01% 3158
2018
Q3
Sell
-10,500
Closed -$11K 2308
2018
Q2
$11K Buy
+10,500
New +$1.71M ﹤0.01% 2135
2013
Q4
Sell
-100,500
Closed -$97K 1552
2013
Q3
$97K Buy
100,500
+25,500
+34% +$1.88M ﹤0.01% 1217
2013
Q2
$484K Buy
+75,000
New +$4.92M 0.01% 814

Other funds holding CME

HighTower Advisors's CME Position: Q1 2026 in Review

HighTower Advisors increased its CME Group (CME) stake by 6% in Q1 2026, buying an estimated $6.31M and bringing the position to 374,178 shares worth $111M. The position accounts for 0.12% of the portfolio, ranked #178.

HighTower Advisors first reported a position in CME in Q3 2013 and has held it in 50 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • HighTower Advisors held 374,178 shares of CME Group worth $111M as of Q1 2026.
  • HighTower Advisors bought 21,256 CME Group shares in Q1 2026, an estimated $6.31M.
  • CME Group made up 0.12% of HighTower Advisors's portfolio in Q1 2026, its #178 holding.
  • HighTower Advisors first reported a position in CME Group in Q3 2013 and has held it in 50 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.